高级检索
当前位置: 首页 > 详情页

Cohort profile: Risk evaluation of cancers in Chinese diabetic individuals: A longitudinal (REACTION) study

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Shanghai Jiao Tong Univ, Key Lab Endocrine & Metab Dis, Minist Hlth, Rui Jin Hosp,Sch Med,E Inst Shanghai Univ, Shanghai 200025, Peoples R China [2]Shanghai Jiao Tong Univ, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis, Dept Endocrine & Metab Dis,Rui Jin Hosp,Sch Med, Shanghai 200025, Peoples R China [3]Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai 200025, Peoples R China [4]Peoples Liberat Army Gen Hosp, Beijing, Peoples R China [5]Shandong Prov Hosp, Jinan, Peoples R China [6]Jiangsu Prov Hosp Integrat Chinese & Western Med, Nanjing, Jiangsu, Peoples R China [7]Nanjing Univ, Sch Med, Nanjing 210008, Jiangsu, Peoples R China [8]Huazhong Univ Sci & Technol, Sch Med, Wuhan Xiehe Hosp, Wuhan 430074, Peoples R China [9]Wuhan Tongji Hosp, Wuhan, Peoples R China [10]Guizhou Univ, Sch Med, Guiyang 550003, Peoples R China [11]Univ Haerbin, Sch Med, Harbin, Peoples R China [12]Univ Luzhou, Sch Med, Luzhou, Peoples R China [13]Xinjiang Kelamayi Peoples Hosp, Kelamayi, Peoples R China [14]Zhongshan Univ, Sch Med, Guangzhou, Guangdong, Peoples R China [15]Jilin Univ, Sch Med, Changchun 130023, Peoples R China [16]Guangxi Univ, Sch Med, Nanning 530004, Peoples R China [17]Lanzhou Univ, Sch Med, Lanzhou 730000, Peoples R China [18]Univ Fujian, Sch Med, Fuzhou, Peoples R China [19]Jiangxi Peoples Hosp, Nanchang, Peoples R China [20]Dalian Univ, Sch Med, Dalian 116012, Peoples R China [21]Zhejiang Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China [22]Anhui Univ, Sch Med, Hefei 230039, Peoples R China [23]Univ Zhenzhou, Sch Med, Zhengzhou, Peoples R China [24]Chongqing Univ, Sch Med, Chongqing 630044, Peoples R China [25]Wenzhou Univ, Sch Med, Wenzhou, Peoples R China [26]Univ Shangdong, Sch Med, Qilu Hosp, Jinan, Peoples R China [27]Johns Hopkins Univ, Sch Med, Baltimore, MD USA [28]Mt Sinai Sch Med, New York, NY USA [29]Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
出处:
ISSN:

关键词: cancer diabetes REACTION study

摘要:
ObjectiveTo demonstrate whether abnormal glucose metabolism (diabetes and prediabetes) is associated with increased risk for cancer in the Chinese population and to identify factors that modify the risk of cancer among individuals with abnormal glucose metabolism. MethodsBetween 2011 and 2012, 259657 community-dwelling adults, aged 40 years and older, were recruited from 25 centers across mainland China to participant in the baseline survey of the REACTION study, with follow-up investigations performed 3, 5, and 10 years later. Detailed questionnaires about lifestyles, physical and biochemical measurement, bio-samples including serum, urine, and whole blood for DNA extraction were collected for all the participants. ResultsThe mean standard deviation (SD) age of this cohort was 5710 years. And the prevalence of pre-existing and newly diagnosed diabetes was 10.32% and 10.57%, respectively. A total of 4511 prevalent cancer cases (988 men and 3523 women) were identified, the prevalence was 1.79. Compared to those with normal glucose metabolism, men with diabetes had a significantly lower adjusted prevalence ratio (PR) of stomach cancer (PR: 0.38, 95% CI: 0.16-0.89), and women with diabetes had significantly higher adjusted PRs of cancer of all sites (PR: 1.36, 95% CI: 1.20-1.56), and cancer of the breast (PR: 1.56, 95% CI: 1.21-2.00), the endometrium (PR: 1.58, 95% CI: 1.16-2.15), and the thyroid (PR: 1.53, 95% CI: 1.03-2.27). ConclusionThe multi-center REACTION study has captured a broad range of data on physical, psychological and metabolic function as well as health status, biochemical and lifestyle information in 259657 adults from the general population across the China.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2013]版:
大类 | 3 区 医学
小类 | 3 区 内分泌学与代谢
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 内分泌学与代谢
JCR分区:
出版当年[2012]版:
Q2 ENDOCRINOLOGY & METABOLISM
最新[2023]版:
Q2 ENDOCRINOLOGY & METABOLISM

影响因子: 最新[2023版] 最新五年平均 出版当年[2012版] 出版当年五年平均 出版前一年[2011版] 出版后一年[2013版]

第一作者:
第一作者单位: [1]Shanghai Jiao Tong Univ, Key Lab Endocrine & Metab Dis, Minist Hlth, Rui Jin Hosp,Sch Med,E Inst Shanghai Univ, Shanghai 200025, Peoples R China [2]Shanghai Jiao Tong Univ, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis, Dept Endocrine & Metab Dis,Rui Jin Hosp,Sch Med, Shanghai 200025, Peoples R China
通讯作者:
通讯机构: [1]Shanghai Jiao Tong Univ, Key Lab Endocrine & Metab Dis, Minist Hlth, Rui Jin Hosp,Sch Med,E Inst Shanghai Univ, Shanghai 200025, Peoples R China [2]Shanghai Jiao Tong Univ, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis, Dept Endocrine & Metab Dis,Rui Jin Hosp,Sch Med, Shanghai 200025, Peoples R China [*1]Shanghai Jiao Tong Univ, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis, Dept Endocrinol & Metab,Rui Jin Hosp,Sch Med, 197 Rui Jin 2nd Rd, Shanghai 200025, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:432 今日访问量:1 总访问量:413 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)